NCT00995449View on ClinicalTrials.gov

Study of KB003 In Biologics-Inadequate Rheumatoid Arthritis

PHASE2TerminatedINTERVENTIONAL

Enrollment

9

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

March 31, 2011

Study Completion Date

February 29, 2012

Conditions

Rheumatoid Arthritis

Interventions

BIOLOGICAL

KB003

KB003 IV x5 doses

OTHER

Placebo Comparator

Placebo IV x5 doses

Trial Locations (11)

20902

Wheaton

21702

Frederick

28401

Wilmington

33143

Miami

53154

Oak Creek

63117

St Louis

63141

St Louis

74135

Tulsa

91361

Westlake Village

94304

Stanford

96813

Honolulu

Sponsors

Lead Sponsor

Humanigen, Inc.

All Listed Sponsors

lead

Humanigen, Inc.

INDUSTRY